NeueHealth (NYSE:NEUE) Director Scott Sandell Sells 4,195 Shares of Stock

NeueHealth, Inc. (NYSE:NEUE) Director Scott Sandell sold 4,195 shares of the company’s stock in a transaction dated Thursday, October 2nd. The shares were sold at an average price of $6.75, for a total transaction of $28,316.25. Following the completion of the transaction, the director owned 488,702 shares in the company, valued at approximately $3,298,738.50. This trade represents a 0.85% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link.

NeueHealth Price Performance

Shares of NEUE stock opened at $6.75 on Tuesday. The firm has a 50 day moving average price of $6.72 and a two-hundred day moving average price of $6.73. The company has a market capitalization of $60.94 million, a PE ratio of -0.42 and a beta of 0.59. NeueHealth, Inc. has a 12-month low of $3.79 and a 12-month high of $7.66.

NeueHealth (NYSE:NEUE) last posted its earnings results on Thursday, August 7th. The company reported ($1.68) EPS for the quarter, beating the consensus estimate of ($4.77) by $3.09. The firm had revenue of $209.08 million during the quarter, compared to analyst estimates of $249.50 million. As a group, research analysts expect that NeueHealth, Inc. will post -9.13 EPS for the current year.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of NeueHealth in a report on Saturday, September 27th. One research analyst has rated the stock with a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, NeueHealth currently has an average rating of “Reduce” and a consensus price target of $7.00.

Institutional Investors Weigh In On NeueHealth

A hedge fund recently bought a new stake in NeueHealth stock. PenderFund Capital Management Ltd. purchased a new stake in NeueHealth, Inc. (NYSE:NEUE) in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 29,115 shares of the company’s stock, valued at approximately $197,000. PenderFund Capital Management Ltd. owned 0.33% of NeueHealth at the end of the most recent quarter. 63.88% of the stock is currently owned by hedge funds and other institutional investors.

About NeueHealth

NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.